Correlation Between Johnson Johnson and Novavax

Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Johnson Johnson and Novavax, you can compare the effects of market volatilities on Johnson Johnson and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Novavax.

Diversification Opportunities for Johnson Johnson and Novavax

0.71

Correlation Coefficient

Johnson Johnson  Novavax

Poor diversification

The 3 months correlation between Johnson and Novavax is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Novavax go up and down completely randomly.

Pair Corralation between Johnson Johnson and Novavax

Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Novavax. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 7.59 times less risky than Novavax. The stock trades about -0.02 of its potential returns per unit of risk. The Novavax is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  886.00  in Novavax on September 17, 2024 and sell it today you would earn a total of  25.00  from holding Novavax or generate 2.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Johnson Johnson  vs.  Novavax

Johnson Johnson

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest uncertain performance, the Stock's basic indicators remain steady and the new chaos on Wall Street may also be a sign of medium-term gains for the company stakeholders.

Novavax

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novavax has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Johnson Johnson and Novavax

The main advantage of trading using opposite Johnson Johnson and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.

The idea behind Johnson Johnson and Novavax pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.